• Home   ›
  •   Global Tenders   › Tender Reference No: 100134467

    • Tenders Are Invited For Pharmaceutical Specialties Based On Eculizumab And Ravulizumab

    Tender Detail

    100134467
    You can view only after subscription.
    PPP0KC-2452/5965/HECAPP/2025/PO/ECULIZUMAB ET RAVULIZUMAB_001
    Self-Funded
    Tenders Are Invited For Pharmaceutical Specialties Based On Eculizumab And Ravulizumab
    NCB
    You can view only after subscription.
    Western Europe
    European Union
    18-09-2025

    Work Detail

    New Patients Will Be Subject To This Public Market, Patients Currently Under Treatment Must Not Be Changed. The Doctor Will Keep The Possibility Of Using The Molecule Best Suited To The Patients Needs.

    Key Value

    Tender Value
    Refer document

    Attachment

    FileName File Description
    Global Tender Document Tender Notice
    Attachments
    Click Here To Download
    Tender Documents

    Additional Details Available on Click
    ✓ Tendering Authority
    ✓ Publication Document
    (Tender Document / Tender Notice )
    RBbranding
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    RBTendersdetails2
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail